arrow
A

Anna Norhammar

karolinska institutet
H指数:51
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Cardiovascular Outcomes of Insulin Degludec Versus Insulin Glargine in Trial-Eligible and Ineligible Populations: A DEVOTE-Inspired Target Trial Emulation Using the Swedish National Diabetes Register

德谷胰岛素与甘精胰岛素在符合试验和不符合试验人群中的心血管结局:一项受DEVOTE试验启发的目标试验模拟,使用瑞典国家糖尿病登记数据

2026-10-210
OA
Effect of empagliflozin on copeptin levels in patients with recent acute coronary syndrome and newly detected dysglycaemia: a post-hoc analysis of the SOCOGAMI randomized controlled trial

恩格列净对近期急性冠状动脉综合征伴新发糖代谢紊乱患者copeptin水平的影响:SOCOGAMI随机对照试验的事后分析

2026-07-280
OA
SGLT2 inhibitor or metformin as standard treatment in early-stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register-based randomised trial on prevention of diabetic complications

SGLT2抑制剂或二甲双胍作为早期2型糖尿病的标准治疗方案?SMARTEST研究基线数据,一项关于预防糖尿病并发症的新型、去中心化、基于登记的随机试验

2025-11-010
PRE